Related Experiment Videos
Impaired granulocyte function in patients with diabetes mellitus
The Tokai Journal of Experimental and Clinical Medicine
|January 1, 1982
Summary
Diabetic patients, especially those on insulin, show reduced granulocyte intracellular killing of Staphylococcus aureus. This impaired bacterial killing may explain increased infection risk in advanced diabetes.
Area of Science:
- Immunology
- Endocrinology
- Microbiology
Background:
- Diabetes mellitus is associated with an increased risk of infections.
- The role of granulocyte function in diabetic patients' susceptibility to bacterial infections requires further elucidation.
Purpose of the Study:
- To investigate the phagocytic and intracellular killing capacities of granulocytes against Staphylococcus aureus in diabetic patients.
- To compare these functions between insulin-treated, diet-treated diabetic patients, and healthy controls.
Main Methods:
- Granulocyte function assays were performed on blood samples from diabetic patients and control subjects.
- Phagocytosis and intracellular killing of Staphylococcus aureus were measured.
Main Results:
- Granulocyte phagocytic activity against Staphylococcus aureus showed no significant difference between diabetic and control groups.
- Intracellular killing of Staphylococcus aureus by granulocytes was significantly reduced in insulin-treated diabetic patients compared to controls.
- No significant difference in intracellular killing was observed between diet-treated diabetic patients and controls.
Conclusions:
- Impaired intracellular killing of bacteria by granulocytes may be a key mechanism contributing to the heightened susceptibility to infections in advanced diabetes mellitus.
- Insulin therapy, rather than diet alone, may be associated with this functional deficit in granulocytes.